[HTML][HTML] A ferroptosis-related gene signature identified as a novel prognostic biomarker for colon cancer
Background Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer.
X Qi, R Wang, Y Lin, D Yan, J Zuo, J Chen… - Frontiers in …, 2021 - europepmc.org
Background Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
[PDF][PDF] A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
X Qi, R Wang, Y Lin, D Yan, J Zuo, J Chen, B Shen - ruiprime.cn
Background: Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
X Qi, R Wang, Y Lin, D Yan, J Zuo… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
[PDF][PDF] A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
X Qi, R Wang, Y Lin, D Yan, J Zuo, J Chen, B Shen - ruiprime.cn
Background: Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
[PDF][PDF] A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
X Qi, R Wang, Y Lin, D Yan, J Zuo, J Chen, B Shen - biowr.github.io
Background: Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …
[HTML][HTML] A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
X Qi, R Wang, Y Lin, D Yan, J Zuo, J Chen… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background Colon cancer (CC) is a common gastrointestinal malignant tumor with high
heterogeneity in clinical behavior and response to treatment, making individualized survival …
heterogeneity in clinical behavior and response to treatment, making individualized survival …